A variant Sp1 (R218Q) transcription factor might enhance HbF expression in β0-thalassaemia homozygotes
- 1 March 2018
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 180 (5) , 755-757
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Analysis of protein-coding genetic variation in 60,706 humansNature, 2016
- The genetic basis of asymptomatic codon 8 frame-shift (HBB:c25_26delAA) β0-thalassaemia homozygotesBritish Journal of Haematology, 2016
- Genetic Modifiers in β-Thalassemia Intermedia: A Study on 102 Iraqi Arab PatientsGenetic Testing and Molecular Biomarkers, 2015
- Sp1 and the ‘hallmarks of cancer’The FEBS Journal, 2015
- Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobinNature Genetics, 2010
- A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15Nature Genetics, 2007
- Methylation-enhanced binding of Sp1 to the stage selector element of the human gamma-globin gene promoter may regulate development specificity of expression.Molecular and Cellular Biology, 1993
- Interaction of Sp1 with the human gamma globin promoter: binding and transactivation of normal and mutant promotersBlood, 1991
- A naturally occurring gamma globin gene mutation enhances SP1 binding activity.Molecular and Cellular Biology, 1990
- Increased Sp1 binding mediates erythroid-specific overexpression of a mutated (HPFH) γ-globulin promoterNucleic Acids Research, 1989